These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6525212)

  • 1. Serum tobramycin levels in low- and very low-birthweight infants.
    Cordero L; Arwood L; Hann C; Visconti J
    Am J Perinatol; 1984 Apr; 1(3):242-6. PubMed ID: 6525212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum netilmicin levels in premature AGA infants.
    Cordero L; Arwood L; DeCenzo S; Visconti J
    Am J Perinatol; 1987 Jan; 4(1):36-40. PubMed ID: 3790215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobramycin pharmacokinetics in very low birth weight infants.
    Nahata MC; Powell DA; Durrell DE; Miller MA
    Br J Clin Pharmacol; 1986 Mar; 21(3):325-7. PubMed ID: 3964533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
    Muth L; Edén T
    Acta Chir Scand; 1981; 147(5):339-46. PubMed ID: 7324760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kinetics of tobramycin in newborn infants in intensive care].
    Guillois B; Guedes Y; Le Guen E; Le Bot MA; Riche C; Alix D
    Pathol Biol (Paris); 1986 May; 34(5):346-8. PubMed ID: 3534704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age.
    van den Anker JN; Schoemaker RC; Hop WC; van der Heijden BJ; Weber A; Sauer PJ; Neijens HJ; de Groot R
    Clin Pharmacol Ther; 1995 Dec; 58(6):650-9. PubMed ID: 8529330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic study of cefotaxime in newborn infants and infants].
    Bégué P; Safran C; Sarlangue J; Quinet B; Martin C
    Arch Fr Pediatr; 1985; 42(7):547-50. PubMed ID: 4083974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin and tobramycin in neonates: comparison of a new extended dosing interval regimen with a traditional multiple daily dosing regimen.
    Avent ML; Kinney JS; Istre GR; Whitfield JM
    Am J Perinatol; 2002 Nov; 19(8):413-20. PubMed ID: 12541213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of gentamicin therapy in very low birth weight infants.
    Koren G; Leeder S; Harding E; Jacques D; MacLeod SM
    Pediatr Pharmacol (New York); 1985; 5(1):79-87. PubMed ID: 3991255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin levels are not related to Apgar score in low birth weight and very low birth weight infants.
    Su PH; Wang SL; Chen JY; Hu JM; Chang HP; Chen SJ
    Early Hum Dev; 2008 Aug; 84(8):533-8. PubMed ID: 18252270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palivizumab use in very premature infants in the neonatal intensive care unit.
    Wu SY; Bonaparte J; Pyati S
    Pediatrics; 2004 Nov; 114(5):e554-6. PubMed ID: 15520088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sodium balance in premature infants].
    Prekajski NB; Ljujić M; Dudić S; Ranković M
    Srp Arh Celok Lek; 1998; 126(1-2):6-12. PubMed ID: 9525076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic studies on parenteral infusion of tobramycin in newborn and premature infants].
    Toyonaga Y; Sugita M; Kurosu Y; Hori M
    Jpn J Antibiot; 1983 Oct; 36(10):2856-68. PubMed ID: 6674521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum concentration of gentamicin in newborn infants].
    Töpke B; Buchenau W; Karstädt U; Linke M; Schlenstein S
    Kinderarztl Prax; 1990 Apr; 58(4):191-7. PubMed ID: 2366406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin dosage recommendations for neonates based on half-life predictions from birthweight.
    Charlton CK; Needelman H; Thomas RW; Kortas K
    Am J Perinatol; 1986 Jan; 3(1):28-32. PubMed ID: 3942611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum concentrations of ceftazidime and tobramycin in newborn infants.
    Tessin I; Thiringer K; Trollfors B; Brorson JE
    Eur J Pediatr; 1988 May; 147(4):405-7. PubMed ID: 3294015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential biochemical growth markers in premature infants.
    Bhandari V; Fall P; Raisz L; Rowe J
    Am J Perinatol; 1999; 16(7):339-49. PubMed ID: 10614701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.